Literature DB >> 27582214

Alzheimer's disease: Attack on amyloid-β protein.

Eric M Reiman1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27582214     DOI: 10.1038/537036a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  7 in total

Review 1.  Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup.

Authors:  Reisa A Sperling; Clifford R Jack; Sandra E Black; Matthew P Frosch; Steven M Greenberg; Bradley T Hyman; Philip Scheltens; Maria C Carrillo; William Thies; Martin M Bednar; Ronald S Black; H Robert Brashear; Michael Grundman; Eric R Siemers; Howard H Feldman; Rachel J Schindler
Journal:  Alzheimers Dement       Date:  2011-07       Impact factor: 21.566

Review 2.  Developing therapeutic antibodies for neurodegenerative disease.

Authors:  Y Joy Yu; Ryan J Watts
Journal:  Neurotherapeutics       Date:  2013-07       Impact factor: 7.620

3.  Associations between biomarkers and age in the presenilin 1 E280A autosomal dominant Alzheimer disease kindred: a cross-sectional study.

Authors:  Adam S Fleisher; Kewei Chen; Yakeel T Quiroz; Laura J Jakimovich; Madelyn Gutierrez Gomez; Carolyn M Langois; Jessica B S Langbaum; Auttawut Roontiva; Pradeep Thiyyagura; Wendy Lee; Napatkamon Ayutyanont; Liliana Lopez; Sonia Moreno; Claudia Muñoz; Victoria Tirado; Natalia Acosta-Baena; Anne M Fagan; Margarita Giraldo; Gloria Garcia; Matthew J Huentelman; Pierre N Tariot; Francisco Lopera; Eric M Reiman
Journal:  JAMA Neurol       Date:  2015-03       Impact factor: 18.302

4.  The antibody aducanumab reduces Aβ plaques in Alzheimer's disease.

Authors:  Jeff Sevigny; Ping Chiao; Thierry Bussière; Paul H Weinreb; Leslie Williams; Marcel Maier; Robert Dunstan; Stephen Salloway; Tianle Chen; Yan Ling; John O'Gorman; Fang Qian; Mahin Arastu; Mingwei Li; Sowmya Chollate; Melanie S Brennan; Omar Quintero-Monzon; Robert H Scannevin; H Moore Arnold; Thomas Engber; Kenneth Rhodes; James Ferrero; Yaming Hang; Alvydas Mikulskis; Jan Grimm; Christoph Hock; Roger M Nitsch; Alfred Sandrock
Journal:  Nature       Date:  2016-09-01       Impact factor: 49.962

Review 5.  Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide.

Authors:  Christian Haass; Dennis J Selkoe
Journal:  Nat Rev Mol Cell Biol       Date:  2007-02       Impact factor: 94.444

Review 6.  CAP--advancing the evaluation of preclinical Alzheimer disease treatments.

Authors:  Eric M Reiman; Jessica B Langbaum; Pierre N Tariot; Francisco Lopera; Randall J Bateman; John C Morris; Reisa A Sperling; Paul S Aisen; Allen D Roses; Kathleen A Welsh-Bohmer; Maria C Carrillo; Stacie Weninger
Journal:  Nat Rev Neurol       Date:  2015-09-29       Impact factor: 42.937

Review 7.  The amyloid hypothesis of Alzheimer's disease at 25 years.

Authors:  Dennis J Selkoe; John Hardy
Journal:  EMBO Mol Med       Date:  2016-06-01       Impact factor: 12.137

  7 in total
  14 in total

Review 1.  Alzheimer disease in 2016: Putting AD treatments and biomarkers to the test.

Authors:  Eric M Reiman
Journal:  Nat Rev Neurol       Date:  2017-01-13       Impact factor: 42.937

2.  Defragmentation of lysozyme derived Amyloid β fibril using Biocompatible Magnetic fluid.

Authors:  Nidhi P Parikh; Kinnari H Parekh
Journal:  J Mater Sci Mater Med       Date:  2018-11-03       Impact factor: 3.896

3.  Hyperbaric Oxygen Prevents Cognitive Impairments in Mice Induced by D-Galactose by Improving Cholinergic and Anti-apoptotic Functions.

Authors:  Chunxia Chen; Luying Huang; Zhihuan Nong; Yaoxuan Li; Wan Chen; Jianping Huang; Xiaorong Pan; Guangwei Wu; Yingzhong Lin
Journal:  Neurochem Res       Date:  2017-01-11       Impact factor: 3.996

4.  Is Beta-Amyloid Accumulation a Cause or Consequence of Alzheimer's Disease?

Authors:  Shaoxun Wang; Paige N Mims; Richard J Roman; Fan Fan
Journal:  J Alzheimers Parkinsonism Dement       Date:  2016-11-17

5.  Parsing disease-relevant protein modifications from epiphenomena: perspective on the structural basis of SOD1-mediated ALS.

Authors:  N D Schmitt; J N Agar
Journal:  J Mass Spectrom       Date:  2017-07       Impact factor: 1.982

Review 6.  Converging pathways in neurodegeneration, from genetics to mechanisms.

Authors:  Li Gan; Mark R Cookson; Leonard Petrucelli; Albert R La Spada
Journal:  Nat Neurosci       Date:  2018-09-26       Impact factor: 24.884

Review 7.  APP as a Protective Factor in Acute Neuronal Insults.

Authors:  Dimitri Hefter; Andreas Draguhn
Journal:  Front Mol Neurosci       Date:  2017-02-02       Impact factor: 5.639

8.  D-4F decreases the expression of Aβ protein through up-regulating long non coding RNA sirt1-as in SAMP8 mice.

Authors:  Xiao-Han Ding; Jie Han; Yuan Liu; Ying Jin; Ping Ye
Journal:  Saudi Pharm J       Date:  2017-05-19       Impact factor: 4.330

9.  Opening the debate on deep brain stimulation for Alzheimer disease - a critical evaluation of rationale, shortcomings, and ethical justification.

Authors:  Merlin Bittlinger; Sabine Müller
Journal:  BMC Med Ethics       Date:  2018-06-11       Impact factor: 2.652

10.  UB-311, a novel UBITh® amyloid β peptide vaccine for mild Alzheimer's disease.

Authors:  Chang Yi Wang; Pei-Ning Wang; Ming-Jang Chiu; Connie L Finstad; Feng Lin; Shugene Lynn; Yuan-Hung Tai; Xin De Fang; Kesheng Zhao; Chung-Ho Hung; Yiting Tseng; Wen-Jiun Peng; Jason Wang; Chih-Chieh Yu; Be-Sheng Kuo; Paul A Frohna
Journal:  Alzheimers Dement (N Y)       Date:  2017-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.